Oxford University scientists have begun testing the safety of a candidate booster vaccine against Ebola, to find out whether it could further increase the immune responses seen in 30 healthy volunteers.
All the adult volunteers have previously received an experimental Ebola vaccine being developed by GSK and the US National Institutes of Health (NIH) as part of an ongoing trial at the Jenner Institute at Oxford University.